A detailed history of Burns J W & CO Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Burns J W & CO Inc holds 5,430 shares of NVO stock, worth $461,550. This represents 0.08% of its overall portfolio holdings.

Number of Shares
5,430
Previous 5,330 1.88%
Holding current value
$461,550
Previous $760,000 15.0%
% of portfolio
0.08%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$119.07 - $145.42 $11,907 - $14,541
100 Added 1.88%
5,430 $646,000
Q1 2024

Apr 17, 2024

BUY
$102.11 - $135.92 $36,759 - $48,931
360 Added 7.24%
5,330 $684,000
Q4 2023

Jan 18, 2024

BUY
$87.78 - $105.45 $54,423 - $65,379
620 Added 14.25%
4,970 $514,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $197,794 - $433,999
2,175 Added 100.0%
4,350 $395,000
Q3 2021

Oct 13, 2021

BUY
$84.42 - $106.62 $183,613 - $231,898
2,175 New
2,175 $209,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Burns J W & CO Inc Portfolio

Follow Burns J W & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burns J W & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Burns J W & CO Inc with notifications on news.